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Abstract: Hair pulling disorder (HPD; trichotillomania) is thought to be 
associated with significant psychiatric comorbidity and functional impairment. 
However, few methodologically rigorous studies of HPD have been conducted, 
rendering such conclusions tenuous. The following study examined 
comorbidity and psychosocial functioning in a well-characterized sample of 
adults with HPD (N=85) who met DSM-IV criteria, had at least moderate hair 
pulling severity, and participated in a clinical trial. Results revealed that 
38.8% of individuals with HPD had another current psychiatric diagnosis and 
78.8% had another lifetime (present and/or past) psychiatric diagnosis. 
Specifically, HPD showed substantial overlap with depressive, anxiety, 
addictive, and other body-focused repetitive behavior disorders. The 
relationships between certain comorbidity patterns, hair pulling severity, 
current mood and anxiety symptoms, and quality of life were also examined. 
Results showed that current depressive symptoms were the only predictor of 
quality of life deficits. Implications of these findings for the conceptualization 
and treatment of HPD are discussed. 
Keywords: Trichotillomania; Obsessive-Compulsive Disorder; Comorbidity; 
Depression; Quality of life 
1. Introduction 
Hair Pulling Disorder (HPD) is an obsessive-compulsive 
spectrum condition in which individuals pull hairs from their own body, 
resulting in significant hair loss (American Psychiatric Association, 
2013). Subclinical hair pulling is relatively common (i.e., 11%) while 
clinical hair pulling, or diagnosable HPD, is less frequent (Woods et al., 
1996). The lifetime prevalence rate of HPD as defined in DSM-IV-TR is 
estimated at about 0.6% (APA, 2000), but may be as high as 3.4% for 
women and 1.5% for men (Christenson et al., 1991a and Christienson 
et al., 1991b). Studies on the gender distribution of HPD suggest it is 
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more common in females (9:1; Christenson, 1995, Duke et al., 
2009 and Reeve, 1999). 
Research has identified two distinct styles of pulling: 
“automatic” and “focused” (Christenson et al., 1991a). Automatic 
pulling is a passive process in which pulling occurs with little conscious 
awareness. In contrast, focused pulling is an active and purposeful 
process, which some suggest, functions to regulate negative affect 
and/or aversive cognitions (Woods et al., 2006b). In either case, hair 
pulling can create a vicious cycle in which both types of pulling are 
present in the same individual: out of awareness (automatic) pulling 
leads to emotional consequences (e.g., sadness, anger, and guilt), 
which can lead to further (focused) pulling (Diefenbach et al., 2002). 
HPD has been consistently associated with negative 
psychosocial consequences. Hair pulling is viewed negatively by peers 
(Woods et al., 1999), can lead to avoidance of social and recreational 
activities (Woods et al., 2006a), and can result in anxiety during 
intimate situations (Christenson and Mansueto, 1999, Diefenbach et 
al., 2005a and Duke et al., 2010). In addition, individuals with HPD 
experience academic, occupational, and psychological difficulties 
(Woods et al., 2006a). Research shows that the majority of people 
with HPD report feeling physical unattractiveness, depression, shame, 
and feelings of low self-worth (Stemberger et al., 2000). 
Beyond measuring specific facets of psychosocial functioning in 
HPD, researchers have also investigated the relationship between HPD 
and global indices of quality of life, with results being mixed. Keuthen 
et al. (2004) found no significant differences on quality of life 
measures between persons with HPD (N=58) and healthy controls 
(from published norms). In contrast, two other studies found that 
persons with HPD (n=28 and 70) had poorer quality of life scores than 
non-psychiatric controls (n=28 and 25) (Diefenbach et al., 
2005b and Odlaug et al., 2010). Three studies (Diefenbach et al., 
2005b, Keuthen et al., 2004 and Tung et al., 2014) with various 
sample sizes (n=28, 58 and 187) found that depression severity 
significantly predicted quality of life, even while controlling for hair 
pulling severity, and a fourth study (Odlaug et al., 2010) (n=70) 
showed that persons with HPD who reported poor quality of life also 
reported higher scores on depression indices. Furthermore, in a related 
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study examining life disability in HPD (N=153), focused hair pulling 
severity and pulling-related distress and interference predicted life 
disability while controlling for depression, but depression also 
correlated with life disability (Tung et al., 2015). These results indicate 
that quality of life and HPD might be at least partially mediated 
through an association with depression. 
Given the difficulties in psychosocial functioning experienced by 
persons with HPD, perhaps it is not surprising that HPD patients are 
generally believed to suffer from comorbid psychiatric disorders at a 
higher rate than the general population. In reviewing the HPD 
literature, 20 studies reported comorbidity rates in adults with HPD, 
but these rates varied widely from study to study. For example, rates 
for comorbid depressive disorders ranged from 14% to 60% 
(Christenson and Mansueto, 1999, Keijsers et al., 2006, van Minnen et 
al., 2003 and Odlaug et al., 2010), anxiety disorders from 2.3% to 
57% (van Minnen et al., 2003 and Christenson et al., 1991a), and 
OCD from 5% to 27% (Christenson et al., 1991a and Schlosser et al., 
1994). It is unclear what factors contributed to these inconsistencies, 
but many of the studies reporting comorbidity rates in HPD possess 
methodological limitations. First, some studies used unstructured 
assessment instruments (e.g., Christenson et al., 
1991a and Christienson et al., 1991b) or (online) self-report measures 
(e.g., Woods et al., 2006a). Second, some studies reported current 
comorbid disorders, while others reported on lifetime comorbidity. 
Third, not all studies were published in peer-reviewed journals (Hand 
et al., 1996). Finally, some study samples did not consist entirely of 
persons with HPD and failed to report statistics specifically for HPD 
(e.g., Grant and Christenson, 2007). 
After 4 studies with significant limitations were set aside, there 
remained 16 studies of sufficient methodological scrutiny that report 
comorbidity rates in HPD. These studies were all published in peer-
reviewed journals, used structured or semi-structured diagnostic 
assessments, used samples that clearly consisted of individuals with 
HPD, and provided clearly delineated results for specific diagnoses 
(e.g., “major depression” rather than “mood disorder”). A summary of 
the characteristics of these studies and their data are presented in 
Table 1, Table 2 and Table 3. Visual analysis of these tables showed 
that comorbidity rates and study characteristics (i.e., sample sizes) 
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still vary considerably across studies. This variability could have been 
caused by the fact that several diagnostic classification systems were 
used in these studies. Also, most studies did not report data on many 
comorbid disorders. Finally, these studies used a variety of recruitment 
practices, meaning that selection bias likely impacted comorbidity 
rates. 
Table 1. Description of former studies examining comorbidity in HPD. 
Reference Sample 
size 
Recruitment Assessment 
Christenson et al., 
1991a and Christienson et al., 
1991b 
60 Referrals from outpatient or 
respondents to newspaper 
ads. Study completed at a 
trichotillomania specialty 
clinic. 
Semi-structured interview 
based on DSM-III-R for HPD 
and comorbid disorders 
Swedo and Leonard (1992)  43 Participants who had 
presented for research studies 
at the National Institutes of 
Mental Health 
Schedule for Affective 
Disorders and Schizophrenia – 
Lifetime Version and the 
Diagnostic Interview for 
Children and Adolescents 
(based on DSM-III-R) 
Schlosser et al. (1994)  22 Participants recruited through 
a psychiatric outpatient clinic 
(N=8) and newspaper 
advertisements (N=14) 
Semi-structured interview 
focused on hair pulling, 
Diagnostic Interview Schedule 
for Axis I Disorders, and 
Structured Interview for DSM-
III-R Personality Disorders 
Christenson (1995)  186 Patients presented at a 
Trichotillomania Clinic 
Minnesota Trichotillomania 
Assessment Inventory based 
on DSM-III-R 
van Minnen et al. (2003)  43 Recruited through television 
ads. Self-referred to university 
outpatient clinic. 
SCID for DSM-IV 
Keijsers et al. (2006)  28 Waitlist control group from 
van Minnen et al. (2003) 
SCID for DSM-IV 
Lochner et al. (2005)  54 Referred to the research unit 
from a wide range of sources 
(e.g., OCD Association of 
South Africa, community-
based primary care 
practitioners, and 
psychiatrists). 
Semi-structured clinical 
interview and SCID-I 
Diefenbach et al., 
2005a and Diefenbach et al., 
2005b 
28 Recruited for participation in 
treatment study 
TDI and SCID 
Woods et al., 2006b and Woods 
et al., 2006 
28 Unclear SCID 
Odlaug and Grant (2008)  24 Recruited from ongoing 
pharmacological treatment 
studies and a longitudinal 
study on impulse control 
disorders 
SCID-I and semi-structured 
interview 
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Reference Sample 
size 
Recruitment Assessment 
Grant et al. (2009)  50 Recruited through newspaper 
ads and referrals from medical 
providers 
Physician-administered TDI 
and SCID 
Lochner et al. (2010)  80 Referred to the research unit 
from a wide range of sources 
(e.g., OCD Association of 
South Africa, community-
based primary care 
practitioners, and 
psychiatrists). 
SCID-I/P, SCID-II/P, SCID-
OCSD, and Trichotillomania 
Behavior Profile 
Odlaug et al. (2010)  70 Participants recruited from 
completed clinical trials 
SCID and SCID-compatible 
modules for impulse control 
disorders 
Keuthen et al. (2012)  38 Unclear Semi-structured interviews for 
DSM-IV diagnoses. Minimum 
MGH-HPS score of 10, HPD 
symptoms for at least 1 year 
Lochner et al. (2012)  84 Self-referred to specialty 
clinics 
SCID-I/P for DSM-IV and 
proposed DSM-5 criteria 
Tung et al. (2015)  153 Participants recruited for two 
research studies at 
Massachusetts General 
Hospital. 
SCID for DSM-IV-TR Axis I 
Disorders Non-patient Edition 
(SCID-I/Np) and Keuthen 
Diagnostic Inventory for Skin 
Picking (K-DISP) 
Table 2. Current comorbidity rates in former studies. 
Disorder Christenson et al., 
1991a and Christi
enson et al., 
1991b 
Schlos
ser et 
al. 
(1994)  
Diefenbach et 
al., 
2005a and Diefe
nbach et al., 
2005b 
Wood
s et 
al. 
(2006
a)  
Gran
t et 
al. 
(200
9)  
Odla
ug et 
al. 
(201
0)  
Lochn
er et 
al. 
(2012
)  
Odla
ug et 
al. 
(201
0)  
Tung 
et al. 
(201
5)  
Avera
ge 
Excoriat
ion 
disorder 
– – – – – – – – 21.6 21.6 
OCD – – – – – – 5 0 22.9 9.3 
Major 
depressi
on 
23 18 21.4 28.6 28 – 8 0 9.4 17.1 
Dysthy
mia 
– – – – – – 5 – 2.7 3.9 
Bipolar – – – – – – 0 – 0.7 0.4 
Panic 
disorder 
– 14 3.6 3.6 – – 2 – 4.6 5.6 
Social 
phobia 
– – – – – – 5 – 0.1 2.6 
Specific 
phobia 
– – – – – – 12 – 6 9 
GAD – – – – – – 14 – 16.6 15.3 
PTSD – – 3.6 – – – 0 – 3.3 2.3 
Eating 
disorder 
– 5 – – – – 1 – 4.6 3.5 
Substan
ce use 
disorder 
– 14 – – – 0 – 4.2 3.3 5.4 
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Disorder Christenson et al., 
1991a and Christi
enson et al., 
1991b 
Schlos
ser et 
al. 
(1994)  
Diefenbach et 
al., 
2005a and Diefe
nbach et al., 
2005b 
Wood
s et 
al. 
(2006
a)  
Gran
t et 
al. 
(200
9)  
Odla
ug et 
al. 
(201
0)  
Lochn
er et 
al. 
(2012
)  
Odla
ug et 
al. 
(201
0)  
Tung 
et al. 
(201
5)  
Avera
ge 
Psychoti
c 
disorder 
NOS 
– – – – – 18 – – – 18 
 
Table 3. Lifetime comorbidity rates in former studies. 
Disorder Christenson et al., 
1991a and Christie
nson et al., 1991b 
Swedo 
and 
Leona
rd 
(1992
)  
Christens
on 
(1995)  
Schloss
er et al. 
(1994)  
Lochn
er et 
al. 
(2005
)  
Odlau
g and 
Grant 
(200
8)  
Lochn
er et 
al. 
(2010
)  
Keuth
en et 
al. 
(2012
) 
Tung 
et al. 
(201
5)  
Avera
ge 
Excoriati
on 
disorder 
– – – – – – – – 24.2 24.2 
OCD 5 16 13.4 27 – 8.3 7.5 – 30.1 15.3 
Major 
depressi
on 
32 39 51.6 41 49 41.7 – 34.2 55 42.9 
Dysthym
ia 
– – 4.8 36 2 – – – 2.7 11.4 
Bipolar 
disorder 
– 5 2.7 – – 0 – – 1.3 2.3 
Panic 
disorder 
18 5 20.8 27 6.1 – – 2.6 11.3 13 
Social 
phobia 
– – 11.3 – 8.2 – – 2.6 10 7.4 
Specific 
phobia 
– 2 18.8 – 18.4 – – 2.6 6.6 12.1 
GAD – 32 27 32 20.4 – – – 16.6 25.6 
PTSD – – – 23 – – – – 9.9 16.5 
Anorexia – 5 1.6 5 2 – – – 4 3.5 
Bulimia – – 8.1 14 6.1 – – 5.3 2 7.1 
Binge 
Eating 
– – – – 10.2 – – – 6 8.1 
Alcohol 
use 
disorder 
– – 19.4 5 – – – 2.6 – 8.9 
Substanc
e use 
disorder 
22 15 16.1 18 – 8.3 – – 21.2 16.8 
Due to the limitations of the literature on comorbidity rates in 
HPD, there is a need to characterize comorbidity patterns in persons 
with HPD using larger and well-characterized samples with 
psychometrically sound and rigorous assessment instruments. These 
results can then be compared to those of previous research in order to 
create better-established norms of HPD comorbidity. The current study 
reports on comorbidity data from a recently completed, federally 
funded clinical treatment trial of adults with HPD (R01MH080966; 
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Woods, PI) that includes one of the top three largest samples of HPD 
collected to date. In addition to describing patterns of comorbidity, the 
relationship between psychiatric comorbidity and psychosocial 
functioning in persons with HPD are explored. 
2. Method 
2.1. Participants 
Eighty-five adults with HPD participated in a randomized 
controlled trial comparing the relative efficacy of Acceptance-Enhanced 
Behavior Therapy to supportive psychotherapy. Participants were 
recruited via local newspaper ads, public transportation flyers, 
newsletters, website advertisements via the Trichotillomania Learning 
Center, and clinic referrals to a university-based HPD specialty clinic. 
The recruitment advertisements stated: 
Are you an adult between the ages of 18 and 65 who pulls their 
hair? If you do, you may be eligible to participate in a research study. 
The Psychology Department at the University of Wisconsin-Milwaukee 
is conducting research on the effectiveness of non-drug treatments for 
hair pulling in adults. The study will take up to 9 months to complete, 
treatment is free, and participants will be paid up to $200 for their 
participation in the study. For more information, please call… 
Inclusion criteria included: (1) a current DSM-IV-TR diagnosis of 
HPD, based on a semi-structured clinical interview; (2) a 
Massachusetts General Hospital Hairpulling Scale score of ≥12; (3) a 
Wechsler Test of Adult Reading score of ≥85; (4) age 18–65; (5) 
ability to speak English fluently; (6) judged able to be maintained on 
outpatient status for the duration of treatment; (7) no initiation or 
change in the dosage of any psychotropic medication for up to eight 
weeks preceding participation in the study or during the course of the 
study; and (8) not currently receiving psychotherapy for HPD or 
another psychiatric condition. 
Exclusionary criteria included: (1) a positive diagnosis of bipolar 
disorder, psychotic or neurocognitive disorder, substance dependence 
(with the exception of nicotine dependence), intellectual disability, or 
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pervasive developmental disorder; and (2) a primary diagnosis of a 
mood or anxiety disorder. In addition, individuals who admitted 
ingesting hair after pulling were eligible for participation only after 
they had received a physical exam from their primary care physician to 
determine if there was any gastrointestinal blockage requiring more 
immediate care. One exception to exclusion criteria was made. A 
single individual who had experienced several periods of depression 
and a single hypomanic episode, thus meeting criteria for Bipolar II, 
was allowed to participate the study after the evaluators and principal 
investigator discussed the case. 
Ninety-one participants (92.2% female; mean age=35.39) 
completed the baseline assessment battery. Most were Caucasian 
(82.3%), 12.9% were Black or African American, 1.2% were Asian, 
1.2% were Hispanic, and 3.5% identified as Other. 
2.2. Measures 
The study utilized a screening questionnaire to assess many 
self-reported aspects of participants' demographics and psychosocial 
functioning. Additionally, several standardized assessment measures 
were used. 
2.2.1. Diagnosis 
The Structured Clinical Interview for DSM-IV Patient Version 
(SCID-P; First et al., 2002) was used to evaluate the presence of 
comorbid psychiatric disorders. The interview provides the trained 
rater with standardized probes about symptoms of DSM-IV disorders 
and provides a scoring algorithm for DSM-IV diagnosis. The SCID-P 
examines both lifetime (present and past) and current diagnoses. 
Lifetime comorbidities were given if the participant met criteria for a 
past and/or current diagnosis. Comorbidities assessed in this study 
were limited to those covered in the SCID-P, as well as HPD and skin 
picking. This study did not assess for Attention Deficit/Hyperactivity 
Disorder, sexual disorders, and personality disorders. 
The Trichotillomania Diagnostic Interview (TDI; Rothbaum and 
Ninan, 1994) is a six-item interview that is modeled after the 
Structured Clinical Interview for the DSM-III-R. Although no 
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psychometric data are available for this instrument, it offers a 
structured method for assessing the presence or absence of HPD, and 
is commonly used to diagnose HPD (e.g., Grant et al., 2009, Tolin et 
al., 2007 and Diefenbach et al., 2008). 
2.2.2. Hair pulling severity 
The Massachusetts General Hospital Hairpulling Scale (MGH-
HPS; Keuthen et al., 1995 and O’Sullivan et al., 1995) is a widely used 
self-report severity measure of HPD consisting of two factors: 
“Severity” and “Resistance and Control” (Keuthen et al., 2007). The 
MGH-HPS has 7 items that are scored on a 5-point Likert scale for a 
total ranging from 0 to 28, with higher scores reflecting greater hair 
pulling severity, lower resistance to pulling, and less control over 
pulling. It has demonstrated satisfactory psychometric properties 
( Diefenbach et al., 2005a, Keuthen et al., 1995 and O’Sullivan et al., 
1995). 
The National Institutes of Mental Health Trichotillomania 
Severity Scale (NIMH-TSS; Swedo et al., 1989) is a semi-structured 
clinical interview that asks questions about time spent pulling, 
resistance to pulling urges, distress, and impairment. Possible scores 
range from 0 to 25. The scale has shown adequate psychometric 
properties for assessing HPD in both adults and children ( Diefenbach 
et al., 2005a, Franklin et al., 2011, Stanley et al., 1999 and Swedo et 
al., 1989). 
2.2.3. General psychological functioning 
The Quality of Life Inventory (QOLI; Frisch et al., 1992) is a 32-
item self-report measure that assesses raters' satisfaction with 16 life 
areas. The reliability of the QOLI is adequate, with a temporal stability 
rating of 0.73 and coefficient alpha of 0.79. The measure has also 
demonstrated adequate convergent and discriminant validity. QOLI t-
scores were used in the present analyses and scored according to 
Frisch (1992). 
The Beck Anxiety Inventory (BAI; Beck et al., 1988b and Beck 
et al., 1988a) and The Beck Depression Inventory (BDI; Beck, 1972) 
are widely used to assess anxiety and depression, respectively. Both 
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measures demonstrate strong psychometric properties (Fydrich, 
Dowdall, & Chambless, 1992; Beck et al., 1988b and Beck et al., 
1988a). 
2.3. Procedure 
A multi-gate assessment procedure was used to screen 
participants for eligibility into the study. First, patients were screened 
by telephone. All callers to the HPD clinic were provided information 
about the study and screened for possible participation. If the 
participant appeared to be eligible and interested, he or she was 
scheduled for an initial clinic screening, during which consent was 
obtained and inclusion/exclusion criteria checked. Participants deemed 
ineligible or those not wishing to participate were referred for standard 
clinical services. Over two hundred individuals (274) were screened via 
telephone. Of the 157 who were screened out at the phone stage, 30 
reported having exclusionary diagnoses (24 for bipolar, 4 for 
schizophrenia, 1 for intellectual disability, and 1 for dementia) and 
were never formally assessed for HPD. Within the 117 persons who 
passed the phone screen and came into the clinic for the in-person 
screen, 21 were ineligible. Reasons included subthreshold level of hair 
pulling severity (n=13), lacking an HPD diagnosis (n=5), below 
minimum intelligence (n=1), and primary diagnosis of another mental 
disorder (n=2; i.e., mood disorder). Another 6 participants were lost 
between screening and baseline assessment due to inability to re-
establish contact. 
IRB approval for this project was obtained at Texas A&M 
University (IRB2013-3025) and the University of Wisconsin-Milwaukee 
(IRB09.039), and the study is publicly listed on ClinicalTrials.gov 
(#NCT00872742). The study was performed in compliance with the 
Code of Ethics of the World Medical Association (Declaration of 
Helsinki). Data for this manuscript were obtained from the baseline 
assessment of the treatment trial. 
3. Results 
3.1. Hair pulling and psychosocial functioning 
NOT THE PUBLISHED VERSION; this is the author’s final, peer-reviewed manuscript. The published version may be 
accessed by following the link in the citation at the bottom of the page. 
Psychiatry Research, Vol 239 (May 30, 2016): pg. 12-19. DOI. This article is © Elsevier and permission has been granted 
for this version to appear in e-Publications@Marquette. Elsevier does not grant permission for this article to be further 
copied/distributed or hosted elsewhere without the express permission from Elsevier. 
12 
 
The baseline sample reported moderately severe hair pulling 
according to both the MGH-HPS (M=16.93, SD=4.53) and NIMH-TSS 
(M=14.34, SD=3.64). 
3.2. Comorbidity 
According to the SCID-P (Table 4), the majority of patients 
(78.8%) met criteria for at least one lifetime comorbid psychiatric 
condition, and 38.8% were determined to be currently suffering from 
another Axis I disorder. The most common lifetime comorbid 
conditions were Major Depression, Alcohol Abuse, PTSD, and GAD. The 
most common current comorbid conditions were Excoriation Disorder 
and Generalized Anxiety Disorder, followed by Specific Phobia and 
Obsessive-Compulsive Disorder. 
Table 4. Comorbidity rates in the present sample. 
Diagnosis Current (%) (N=85) Lifetime (%) (N=85) 
Excoriation 12.9 12.9 
OCD 4.7 7.1 
Major depression 3.5 51.8 
Adjustment disorder with depressed mood 2.4 3.5 
Dysthymia 2.4 2.4 
Bipolar 1.2 1.2 
Panic 1.2 8.2 
Social phobia 4.7 8.2 
Specific phobia 5.9 8.2 
GAD 12.9 14.1 
PTSD 1.2 15.3 
Anorexia 0.0 4.7 
Bulimia 0.0 1.2 
Binge eating 0.0 1.2 
Alcohol abuse disorder 2.4 17.7 
Substance abuse disorder 0.0 4.7 
Total 38.8 78.8 
The most notable differences between data from this study and 
average current comorbidity rates from previous studies (See Table 2, 
Table 3 and Table 4; current study data reported first) were on 
Excoriation Disorder (12.9% vs. 21.6%), Major Depression (3.5% vs. 
17.1%), and Obsessive-Compulsive Disorder (4.7% vs. 9.3%). 
Additionally, notable differences for our data and the average lifetime 
comorbidity rates from previous studies were on Excoriation Disorders 
(12.9% vs. 24.2%), OCD (7.1% vs. 15.3%), Specific Phobia (2.4% vs. 
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12.1%), GAD (14.1% vs. 25.6%), Alcohol Abuse Disorder (17.7% vs. 
8.9%), and Substance Abuse Disorder (4.7% vs. 16.8%). 
3.3. Effects of comorbidity, psychosocial functioning, 
and hairpulling on quality of life 
In order to investigate associations between comorbidity, hair 
pulling variables, and measures of psychosocial functioning, we 
conducted multiple correlational analyses comparing BAI, BDI, MGH, 
NIMH-TSS, and the presence of current or lifetime comorbidity to QOLI 
scores. A full correlation matrix is shown in Table 5. Both Pearson and 
point-biserial correlations were used, and due to the propensity for 
multiple comparisons to increase Type I error rates, we used a 
Bonferroni correction to adjust alpha levels. Only BDI scores were 
significantly correlated with the QOLI. This suggests that, in persons 
with HPD, current depressive symptom severity is the best predictor of 
current ratings of quality of life. 
Table 5. Correlation matrix. 
 
MGH-
HPS 
NIMH-
TSS 
BAI BDI Current 
comorbidity 
Lifetime 
comorbidity 
MGH-HPS – − – – – – 
NIMH-TSS 0.62** – – – – – 
BAI 0.19 0.23* – – – – 
BDI 0.25* 0.24* 0.71** – – – 
Current 
comorbidity 
0.02 0.03 0.16 0.22 – – 
Lifetime 
comorbidity 
0.02 0.06 0.22* 0.25* 0.41** – 
Quality of life −0.09 −0.09 −0.13 −0.34** −0.17 −0.19 
**Denotes bonferroni-corrected significance at p<0.002. 
*Denotes significance at p<0.05. 
4. Discussion 
The aims of the current study were to describe psychosocial 
functioning and comorbid psychopathology within a well-characterized 
sample of adults with HPD with moderate hair pulling severity and to 
investigate the relationships between these variables and quality of 
life. 
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In this study, persons with HPD reported quality of life in the 
upper part of the low range, which was very similar to that reported by 
three previous studies utilizing the same measure (Raw score means 
on the QOLI=41.20 vs. 43.00, 44.31, 42.77; Diefenbach et al., 
2005b and Odlaug et al., 2010; Tung, personal communication, 
October 4, 2015). The findings on current levels of depressive and 
anxiety symptoms are not as consistent with previous findings. This 
study showed current depressive and anxiety symptoms to be within 
the minimal to mild range, along with a high degree of variance. 
Although these findings are consistent with that of several studies 
(Diefenbach et al., 2005b and Keuthen et al., 2004, 2012; Odlaug et 
al., 2010), they contrast with Woods et al. (2006a), who reported 
mean depression and anxiety scores in the severe range on the 
Depression Anxiety Stress Scale (DASS-21; Lovibond and Lovibond, 
1995). Perhaps the Woods et al. (2006a) study, which utilized an 
internet sample of self-identified HPD participants, found higher rates 
of depressive and anxiety symptoms due to sampling differences, such 
that persons with HPD who participate in internet-based surveys may 
be more secretive and impaired than those who are willing to 
participate in a clinical trial. 
In reviewing the literature, we found vastly differing rates of 
comorbidity among people diagnosed with HPD. In the current study, 
rates of both lifetime and current psychopathology were high, at 
78.8% and 38.8%, respectively. These rates are elevated as compared 
to community norms, as studies have shown that, in a representative 
community U.S. adult sample, we should expect to find 46% lifetime 
and 26% twelve-month prevalence of at least one psychiatric disorder 
(Kessler et al., 2005b and Kessler et al., 2005a). Specifically, this 
study found high rates of comorbid ExD, Generalized Anxiety Disorder, 
Specific Phobia, Major Depression, PTSD, as well as other anxiety and 
addictive disorders. One finding that has notable implications is that 
comorbid OCD was shown in 7.1% of individuals over their lifetime. 
Proponents of the OCD-spectrum, including HPD, have proposed that 
shared comorbidity is evidence of this relationship, yet our findings 
stand in contrast to such arguments. Evidence from other studies on 
comorbidity rates between OCD and HPD has been mixed, as expert 
reviews have pointed to poor evidence for high comorbidity rates 
(Storch et al., 2008) while the literature review conducted in the 
current study points to high rates of current and lifetime comorbidity. 
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The results from the current study and the mixed findings in the 
literature suggest that more research is needed on the topic. 
There were several notable differences between the comorbidity 
rates found in the current study and those in the HPD literature. The 
direction of those differences was largely in the direction of lower 
estimates of current and lifetime comorbidity in the current study as 
compared to those reported in previous studies. Although the clinical 
trial from which these data were derived did exclude a number of 
individuals with comorbid diagnoses, most exclusions came because of 
self-reported bipolar disorder during the phone screen. Only two 
individuals were excluded for a primary diagnosis of severe 
depression. Differences in the rates of Excoriation Disorder between 
our study and that of Tung et al. (2015) might seem large, but a 
review by Snorrason et al. (2012) showed that comorbidity rates 
between HPD and Excoriation fall between 10% and 34% 
(average=20.8%). Thus, our rate of Excoriation disorder might be 
below average, but not outside the range of other studies. One 
potential reason why lower rates of mood, anxiety, and substance use 
disorders were found in the current study is that individuals with HPD 
in addition to these diagnoses may seek treatment for HPD less 
frequently than persons with HPD alone. While experiencing the effects 
of depression, anxiety, or drug addiction, individuals might view hair 
pulling as a relatively minor problem and be unlikely to seek HPD-
specific treatment. Thus, individuals with HPD who seek treatment for 
HPD might be less likely to be suffering from other conditions, whereas 
the more complicated group of persons with HPD exist in less 
specialized settings. This notion could be seen as consistent with critics 
of the methodology of randomized clinical trials (Westen et al., 2004), 
in that they tend to recruit individuals who lack treatment-complicating 
characteristics such as psychiatric comorbidity, making it difficult to 
generalize their results to real-world settings. 
Although HPD is indeed associated with other psychosocial 
conditions, comorbid diagnoses and hair pulling symptoms do not 
seem to account for deficits in global functioning. Instead, it appears 
that current internalizing symptoms largely account for reductions in 
quality of life, a finding that is consistent with those of previous 
studies (Diefenbach et al., 2005b, Keuthen et al., 2004, Odlaug et al., 
2010, Tung et al., 2014 and Tung et al., 2015). It must, however, be 
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noted that the variable correlating significantly with quality of life, 
depression, was measured continuously and allowed to freely vary, 
whereas some other variables were constrained due to inclusion 
criteria (i.e., MGH≥12). This practice could have attenuated the 
correlation between hair pulling severity as measured by the MGH. 
Thus, a more diverse community and clinical sample of persons with 
HPD and subclinical hair pulling might provide different results. 
The current study has a number of implications for future 
research. First, future investigations should seek to understand 
individuals with HPD who have relatively high psychosocial functioning 
aside from hair pulling. Understanding factors contributing to 
emotional and functional resiliency in the face of moderate to severe 
hair pulling could have important implications for predicting outcomes 
and enhancing treatment. Second, results might clarify how and when 
selective serotonin reuptake inhibitors (SSRIs) should be prescribed 
for persons with HPD. Currently, SSRIs are routinely used to treat HPD 
(Woods et al., 2006a) despite little data supporting their effectiveness 
(Bloch et al., 2007 and McGuire et al., 2014). Data from the current 
study suggest SSRIs may help improve QOL by reducing depressive 
symptoms, even if the medications do little to the pulling symptoms. 
However, even though it has been proposed that individuals with HPD 
who display comorbid mood and anxiety issues may be ideal 
candidates for combined behavioral and pharmacotherapy (Dougherty 
et al., 2006), combined pharmacological and behavioral treatment 
does not always produce enhanced results, as evidenced by treatment 
studies for OCD (Foa et al., 2005). Third, it is conceivable that 
comorbidity rates might decrease as a result of changes in HPD 
diagnostic criteria from DSM-IV to DSM-5. Because DSM-5 removed 
two criteria, this would likely result in more hair pullers receiving the 
HPD diagnosis. Persons with less severe hair pulling would now be 
diagnosed in greater numbers, and these persons would be expected 
to show reduced rates of comorbid anxiety and depression, which are 
thought to often come as a consequence of hair pulling (Diefenbach et 
al., 2002, Keuthen et al., 1998 and Keuthen et al., 2001). 
The primary limitation of this study is that potential participants 
were screened out for some comorbidities that might impact treatment 
(e.g., mania, psychosis, and primary major depression), which creates 
selection bias that undoubtedly affects the results of this study. A 
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related concern is that all individuals in the current study were seeking 
treatment for HPD, which could result in an over-estimation of the 
amount of comorbidities, as these persons are more likely to seek help 
(Du Fort, Newman, and Bland, 1993). Ultimately, in order to provide 
the best estimates of comorbidity, in a TTM community-based 
population, researchers would need to conduct a broad survey of the 
community that reduced selection bias, but HPD was left out of such 
efforts that have already been conducted (i.e., the National 
Comorbidity Study). 
Other limitations to the current study include the lack of a 
psychiatric control group, which limits the ability to determine if these 
psychosocial patterns (i.e., QOL, depression, and anxiety) are specific 
to those with HPD. Furthermore, some additional comorbidities were 
not assessed, although none, other than personality disorders 
(Chamberlain and Odlaug, 2014), have shown substantial comorbidity 
with HPD. Another potential limitation of the current study is that the 
QOLI may not be a highly valid measure for use in HPD. As noted by 
Odlaug et al. (2010), although the QOLI assesses a range of topics 
including self-esteem, it contains no question regarding appearance, 
which can be particularly relevant for persons with HPD. Moreover, the 
QOLI contains no age- or gender-based norms, factors which impact 
quality of life (Hjermstad et al., 1998). Thus, the QOLI norms might 
not accurately reflect quality of life in a sample consisting primarily of 
middle-aged females. These caveats notwithstanding, this study 
contributes substantially to the existing literature regarding 
comorbidity patterns in HPD. Further research attention should be 
directed toward comorbid and internalizing symptoms in hair pulling, 
which might lead to more accurate conceptualizations of HPD clinical 
presentation and associated impairment. 
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